Legal/ Interim Chief Financial Officer
Glen Sato currently is a partner at Cooley LLP and is supporting Scintilla Pharmaceuticals as Interim Chief Financial Officer and Legal support. Glen is responsible for the finance, operations and legal activities of Scintilla Pharmaceuticals and has extensive experience in public offerings, financing and collaborative transactions as well as operational experience in both research and development and commercial biopharmaceutical companies. He was previously Senior Vice President and Chief Financial Officer of PDL BioPharma, Inc. from 2003-2005, and prior to that Senior Vice President, Chief Financial Officer and General Counsel of Exelixis, Inc. from 1999-2003. Glen received his JD and MBA from UCLA, where he was Associate Editor of the Law Review, and received his BA from Wesleyan University.